Schlagwort: BSV
Surging expected growth of drug approvals over the next decade
In March 2024, we reported a gradual increase of new drug approvals over the past 30 years, combined with an increasing focus on cancer,...
Can biopharma’s drug-focused R&D strategy remain profitable?
Since the 1990s, there has been a shift in focus within pharmaceutical R&D. It resulted in placing greater emphasis on areas such as cancer,...